【レポートの概要（一部）】
Table of Content
Chapter 1. Methodology and Scope
1.1. Research methodology
1.2. Research scope & assumption
1.3. List of data sources
Chapter 2. Executive Summary
2.1. Injectable drug delivery market – Industry Summary and Key Buying Criteria, 2013 – 2024
Chapter 3. Injectable Drug DeliveryIndustry Outlook
3.1. Market segmentation
3.2. Market size and growth prospects, 2013 – 2024
3.3. Injectable drug delivery: Market dynamics
3.3.1. Market driver analysis
3.3.1.1. Escalation in demand for self- injection devices
3.3.1.2. Increase in number of chronic diseases
3.3.1.3. Innovative technological progress
3.3.1.4. Development of the biologics market
3.3.2. Market restraint analysis
3.3.2.1. Needle stick injuries and infections
3.3.2.2. Preference over other drug delivery systems
3.3.2.3. Sterility of injectables
3.4. Injectable drug delivery market: Industry trend analysis
3.5. Injectable drug delivery market – PESTEL Analysis
3.6. Injectable drug delivery Industry analysis – Porter’s Five Forces Model
3.7. Injectable drug delivery: Company Market Share Analysis (%), 2015
3.8. Key opportunities prioritized
Chapter 4. Injectable Drug Delivery Product Type Outlook
4.1. Injectable Drug Delivery Revenue Share (%) Analysis, by Product Outlook, 2016 & 2024
4.2. By Devices
4.2.1. Self-injection devices
4.2.1.1. Self-injection devices market revenue, by region, 2013 to 2024 (USD Million)
4.2.2. Conventional devices
4.2.2.1. Conventional drug delivery market revenue, by region, 2013 to 2024 (USD Million)
4.3. By Formulations
4.3.1. Conventional drug delivery
4.3.1.1. Conventional drug delivery market revenue, by region, 2013 to 2024 (USD Million)
4.3.2. Novel drug delivery
4.3.2.1. Novel drug delivery market revenue, by region, 2013 to 2024 (USD Million)
4.4. Others
4.4.1. Others market revenue, by region, 2013 to 2024 (USD Million)
Chapter 5. Injectable Drug Delivery Therapeutic Use Outlook
5.1. Injectable Drug Delivery Revenue Share (%) Analysis, by Therapeutic Use Outlook, 2016& 2024
5.2. Autoimmune disorders
5.2.1. Autoimmune disorders injectable drug delivery market, by region, 2013 to 2024 (USD Million)
5.3. Hormonal disorders
5.3.1. Hormonal disorders injectable drug delivery market, by region, 2013 to 2024 (USD Million)
5.4. Oncology
5.4.1. Oncology injectable drug delivery market, by region, 2013 to 2024 (USD Million)
5.5. Others
5.5.1. Others drug injectable drug delivery market, by region, 2013 to 2024 (USD Million)
Chapter 6. Injectable Drug Delivery End-User Application Outlook
6.1. Injectable Drug Delivery Revenue Share (%) Analysis, by End-User Application, 2016& 2024
6.2. Hospital
6.2.1. Hospital market revenue, by region, 2013 to 2024 (USD Million)
6.3. Homecare Settings
6.3.1. Homecare settings market revenue, by region, 2013 to 2024 (USD Million)
6.4. Others
6.4.1. Others market revenue, by region, 2013 to 2024 (USD Million)
Chapter 7. Injectable Drug Delivery Regional Outlook
7.1. Injectable drug delivery Market Share (%) Analysis, by Region, 2013&2024
7.2. North America
7.2.1. U.S.
7.2.1.1. U.S. injectable drug delivery market, by device, 2013 – 2024 (USD Million)
7.2.1.2. U.S injectable drug delivery market, by formulation, 2013 – 2024 (USD Million)
7.2.1.3. U.S. injectable drug delivery market, by therapeutic use, 2013 – 2024 (USD Million)
7.2.1.4. U.S. injectable drug deliverymarket, by end-user application, 2013 – 2024 (USD Million)
7.2.2. Canada
7.2.2.1. Canada injectable drug delivery market, by device, 2013 – 2024 (USD Million)
7.2.2.2. Canada injectable drug delivery market, by formulation, 2013 – 2024 (USD Million)
7.2.2.3. Canada injectable drug delivery market, by therapeutic use,2013 – 2024 (USD Million)
7.2.2.4.Canada injectable drug delivery market, by end-user application, 2013 – 2024 (USD Million)
7.3. Europe
7.3.1. Germany
7.3.1.1. Germany injectable drug delivery market, by device, 2013 – 2024 (USD Million)
7.3.1.2. Germany injectable drug delivery market by formulation, 2013 – 2024 (USD Million)
7.3.1.3. Germany injectable drug delivery market, by therapeutic use, 2013 – 2024 (USD Million)
7.3.1.4. Germany injectable drug delivery market, by end-user application, 2013 – 2024 (USD Million)
7.3.2. UK
7.3.2.1. UK injectable drug delivery market, by device, 2013 – 2024 (USD Million)
7.3.2.2. UK injectable drug delivery market, by formulation, 2013 – 2024 (USD Million)
7.3.2.3. UK injectable drug delivery market, by therapeutic use, 2013 – 2024 (USD Million)
7.3.2.4. UK injectable drug delivery market, by end-user application, 2013 – 2024 (USD Million)
7.4. Asia-Pacific
7.4.1. China
7.4.1.1. China injectable drug delivery market, by device, 2013 – 2024 (USD Million)
7.4.1.2. China injectable drug delivery market by formulation, 2013 – 2024 (USD Million)
7.4.1.3. China injectable drug delivery market, by therapeutic use, 2013 – 2024 (USD Million)
7.4.1.4. China injectable drug delivery market, by end-user application, 2013 – 2024 (USD Million)
7.4.2. India
7.4.2.1. India injectable drug delivery market, by device, 2013 – 2024 (USD Million)
7.4.2.2. India injectable drug delivery market, by formulation, 2013 – 2024 (USD Million)
7.4.2.3. India injectable drug delivery market, by therapeutic use 2013 – 2024 (USD Million)
7.4.2.4. India injectable drug delivery market, by end-user application, 2013 – 2024 (USD Million)
7.5. MEA
7.5.1. South Africa
7.5.1.1. South Africa injectable drug delivery market, by device, 2012 – 2024 (USD Million)
7.5.1.2. South Africa injectable drug delivery market, by formulation, 2013 – 2024 (USD Million)
7.5.1.3. South Africa injectable drug delivery market, by therapeutic use, 2013 – 2024 (USD Million)
7.5.1.4. South Africa injectable drug deliverymarket, by end-user application, 2013 – 2024 (USD Million)
7.5.2. Saudi Arabia
7.5.2.1. Saudi Arabia injectable drug delivery market, by device, 2013 – 2024 (USD Million)
7.5.2.2. Saudi Arabia injectable drug delivery market, by formulation, 2013 – 2024 (USD Million)
7.5.2.3. Saudi Arabia injectable drug delivery market, by therapeutic use, 2013 – 2024 (USD Million)
7.5.2.4. Saudi Arabia injectable drug delivery market, by end-user application, 2013 – 2024 (USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Brazil injectable drug delivery market, by device, 2013 – 2024 (USD Million)
7.6.1.2. Brazil injectable drug delivery market, by formulation, 2013 – 2024 (USD Million)
7.6.1.3. Brazil injectable drug delivery market, by therapeutic use, 2013 – 2024 (USD Million)
7.6.1.4. Brazil injectable drug deliverymarket, by end-user application, 2013 – 2024 (USD Million)
7.6.2. Mexico
7.6.2.1. Mexico injectable drug delivery market, by device,2013 – 2024 (USD Million)
7.6.2.2. Mexico injectable drug delivery market, by formulation, 2013 – 2024 (USD Million)
7.6.2.3. Mexico injectable drug delivery market, by therapeutic use, 2013 – 2024 (USD Million)
7.6.2.4. Mexico injectable drug delivery market, by end-user application, 2013 – 2024 (USD Million)
Chapter 8. Competitive Landscape
8.1. Pfizer, Inc.
8.1.1. Company Overview
8.1.2. Financial Performance
8.1.3. Product Benchmarking
8.1.4. Strategic Initiatives
8.2. Baxter International, Inc.
8.2.1. Company Overview
8.2.2. Financial Performance
8.2.3. Product Benchmarking
8.2.4. Strategic Initiatives
8.3. Schott AG
8.3.1. Company Overview
8.3.2. Financial Performance
8.3.3. Product Benchmarking
8.3.4. Strategic Initiatives
8.4. Becton, Dickinson and Company
8.4.1. Company Overview
8.4.2. Financial Performance
8.4.3. Product Benchmarking
8.4.4. Strategic Initiatives
8.5. ELI Lily and Company
8.5.1. Company Overview
8.5.2. Financial Performance
8.5.3. Product Benchmarking
8.5.4. Strategic Initiatives
8.6. Alkermes PLC
8.6.1. Company Overview
8.6.2. Financial Performance
8.6.3. Product Benchmarking
8.6.4. Strategic Initiatives
8.7. Terumo Corporation
8.7.1. Company Overview
8.7.2. Financial Performance
8.7.3. Product Benchmarking
8.7.4. Strategic Initiatives
8.8 Elcam Medical
8.8.1. Company Overview
8.8.2. Financial Performance
8.8.3. Product Benchmarking
8.8.4. Strategic Initiatives
8.9 Unilife Corporation
8.9.1. Company Overview
8.9.2. Financial Performance
8.9.3. Product Benchmarking
8.9.4. Strategic Initiatives
【レポート販売概要】
■ タイトル：注射薬物送達の世界市場の収益分析：機器別（自己注射機器、従来の機器）、処方別（従来型薬物送達、新規型薬物送達）、治療使用方法別（自己免疫疾患、ホルモン障害、腫瘍学）、エンドユーザー用途別（病院、ホームケア施設、研究機関、臨床検査室）、地域別（アメリカ、カナダ、ドイツ、英国、中国、インド、南アフリカ、サウジアラビア、ブラジル、メキシコ）、セグメント予測、2013-2024■ 英文：Injectable Drug Delivery Market Analysis, By Device Type (Self-injection Devices, Conventional Devices), By Formulation (Conventional Drug Delivery, Novel Drug Delivery), By Therapeutic Use (Autoimmune Disorders, Hormonal Disorders, Oncology), By End-user Application (Hospitals, Homecare Settings, Research Institutes, Clinical Laboratories), By Region (U.S, Canada, Germany, U.K, China, India, South Africa, Saudi Arabia, Brazil, Mexico) And Segment Forecasts From 2013 to 2024
■ 発行日：2016年8月11日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707435
■ 調査対象地域：グローバル
- ヘッドセットの世界市場分析：製品別（インイヤー、オーバーイヤー）、価格別（USD50未満、USD50～100、USD100以上）、技術別（ワイヤー式、ワイヤレス）、用途別（個人用、商業用）、セグメント予測The headsets market is estimated to reach approximately USD 20,465.7 million by 2024, according to a new study conducted by Grand View Research, Inc. The rise in the disposable income is remarkably driving the demand for application-specific headsets. The increase in consumer spending for consumer electronic products has significantly spurred the market growth. The growing demand for improved desi …
- 窓用フィルムの世界市場分析：製品別（日光調節、装飾、安全･セキュリティ、プライバシー）、エンドユーザー別（自動車、建設（商業、住宅）、海洋）、動向･動態、競争の見通しとセグメント予測、2014-2025The global window films market is expected to reach USD 13.81 billion by 2025, according to a new report by Grand View Research, Inc. Rising environmental awareness regarding carbon dioxide emissions coupled concerns related to energy efficiency are projected to drive demand. Increasing demand from key end-use industries such as automotive, construction, and marine is a major factor that will dete …
- 自動車用エンジン・アクチュエータの世界市場ABSTRACTAbout Automotive Engine Actuators An engine actuator is responsible for moving or controlling the VVT system in electronic throttle system. An actuator requires a control signal or source of energy to act or operate. The required control signal is of relatively low energy, and the source of energy could be electric current or pneumatic/hydraulic pressure. Most of the actuators are powered …
- CMOSイメージセンサーのグローバル市場（2014-2018）About CMOS Image Sensors Image sensors are devices used for the conversion of an image into an electronic signal. Image sensing technology is used in cameras, camcorders, and all types of imaging devices. Before the digital era, analog image sensors functioned with video camera tubes. These tubes have been replaced by digital technologies such as CCD and CMOS image sensors. A CMOS image sensor ope …
- 音声分析ソリューションの世界市場：スピーチエンジン、索引、分析・クエリーツール、ダッシュボード、レポートツールMarketsandMarkets forecasts the speech analytics market size to grow from USD 589.2 Million in 2015 to USD 1.60 Billion by 2020, at a Compound Annual Growth Rate (CAGR) of 22.0% from 2015 to 2020. Today, the multichannel world consists of voice, email, chat, social channels, and surveys, and each channel has its own importance. It has been observed that voice, phone interaction, is the most common …
- 世界のグリセロール・エトキシレート市場2015The Global Glycerol Ethoxylate Industry Report 2015 is a professional and in-depth study on the current state of the Glycerol Ethoxylate industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Glycerol Ethoxylate market analysis is provided for the international markets including development trends, compet …
- Lea County Electric Cooperative, Inc.：発電所及びSWOT分析2013Lea County Electric Cooperative, Inc. - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets …
- 浮腫：治療薬のグローバル治験動向（2014年下半期）Edema Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Edema Global Clinical Trials Review, H2, 2014" provides data on the Edema clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Edema. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across …
- サメ肉の世界市場2019-2023Technavio Announces the Publication of its Research Report – Global Shark Meat Market 2019-2023 Technavio recognizes the following companies as the key players in the global shark meat market: ALL EASY GO FROZEN SEAFOOD CO.,LTD, Aquafin Trade, Inc., East Coast Seafood, LLC, Sea to Table, Inc, WENZHOU HAIDELI SHARK PRODUCTS CO., LTD.. Commenting on the report, an analyst from Technavio’s team said: …
- Mari Gas Company Limited：石油・ガスの開発・生産動向及びコスト分析– 2012Mari Gas Company Limited Oil & Gas Exploration and Production Operations and Cost Analysis – 2012 Summary Mari Gas Company Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential sour …
- BRIC新興国の心臓補助処置動向（～2020）BRIC Cardiac Assist Procedures Outlook to 2020 Summary GlobalData’s new report, "BRIC Cardiac Assist Procedures Outlook to 2020", provides key procedures data on the BRIC Cardiac Assist Procedures. The report provides procedure volumes within market categories – Total Artificial Heart (TAH) Procedures and Ventricular Assist Procedures (Left Ventricular, Right Ventricular, External Ventricular and …
- 車両接近通報装置（AVAS）の世界市場予測（～2027年）“Government mandate for implementation of acoustic vehicle alerting system is significant factors for the growth of the acoustic vehicle alerting system market globally”The acoustic vehicle alerting system market is projected to reach USD 5,615 million by 2027 from an estimated USD 425 million in 2019 considering the installation of AVAS in passenger car and commercial vehicle, at a CAGR of 38.1% …
- 高血圧薬の世界市場2019-2023About this market Patients with hypertension are generally treated with drugs that can reduce blood volume (reducing central venous pressure and cardiac output), reduce systemic vascular resistance, and reduce cardiac output by depressing heart rate and stroke volume. For instance, diuretic drugs decrease the blood volume by increasing urine output by the kidney. Similarly, vasodilator drugs dilat …
- ウェアラブル技術の世界市場：eテキスタイル、ARスマートグラス、ウェアラブルPC、スマートウォッチThe global wearable technology market has thus far not quite delivered upon previous expectations of revenues, consumer adoption and even technological advances. However, 2015 might be the breakthrough year in which wearables begin to achieve that mass market acceptance that has long been expected. One of the main reasons is the entrance of Apple to the SmartWatches market, which will disrupt not …
- Hadoopビッグデータ分析の世界市場予測（～2021）：構成要素別（ソリューション、サービス）、用途別、産業別、地域別The Hadoop big data analytics market is projected to grow from USD 6.71 Billion in 2016 to USD 40.69 Billion by 2021, at a CAGR of 43.4% during the forecast period. Growth in this market is mainly attributed to the increasing volume of big data and growing need for big data analytics. With increase in the volume of big data, companies are looking for ways to analyze and process it quickly and econ …
